SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 147 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 5.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,580 | -11.8% | 241,337 | 0.0% | 0.01% | -7.7% |
| Q2 2023 | $6,328 | +1.9% | 241,337 | 0.0% | 0.01% | -13.3% |
| Q1 2023 | $6,212 | -1.0% | 241,337 | 0.0% | 0.02% | 0.0% |
| Q4 2022 | $6,277 | -99.9% | 241,337 | 0.0% | 0.02% | -16.7% |
| Q3 2022 | $6,885,000 | +15.9% | 241,337 | 0.0% | 0.02% | +20.0% |
| Q2 2022 | $5,942,000 | -56.4% | 241,337 | 0.0% | 0.02% | -48.3% |
| Q1 2022 | $13,621,000 | -8.9% | 241,337 | 0.0% | 0.03% | -3.3% |
| Q4 2021 | $14,958,000 | -2.3% | 241,337 | 0.0% | 0.03% | -9.1% |
| Q3 2021 | $15,310,000 | -23.0% | 241,337 | 0.0% | 0.03% | -23.3% |
| Q2 2021 | $19,889,000 | -5.6% | 241,337 | -15.7% | 0.04% | -14.0% |
| Q1 2021 | $21,066,000 | -12.9% | 286,337 | -14.1% | 0.05% | -21.9% |
| Q4 2020 | $24,174,000 | +52.1% | 333,337 | 0.0% | 0.06% | +36.2% |
| Q3 2020 | $15,890,000 | -10.2% | 333,337 | -20.9% | 0.05% | -16.1% |
| Q2 2020 | $17,694,000 | +55.6% | 421,282 | 0.0% | 0.06% | +21.7% |
| Q1 2020 | $11,375,000 | – | 421,282 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $71,239,818 | 7.97% |
| Finepoint Capital LP | 556,928 | $12,876,175 | 6.41% |
| M28 Capital Management LP | 197,700 | $4,570,824 | 5.24% |
| Boxer Capital, LLC | 3,421,541 | $79,106,028 | 4.21% |
| Deep Track Capital, LP | 3,546,435 | $81,993,577 | 3.16% |
| EcoR1 Capital, LLC | 3,460,208 | $80,000,009 | 2.70% |
| Orbimed Advisors | 3,968,588 | $91,753,755 | 1.95% |
| Artal Group S.A. | 1,816,620 | $42,000 | 1.80% |
| SPHERA FUNDS MANAGEMENT LTD. | 319,911 | $7,396,342 | 1.35% |
| Perceptive Advisors | 1,520,416 | $35,152,017 | 1.17% |